
PMC:7267243 / 17403-17581
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T157 | 40-43 | Disease | denotes | MSD | http://purl.obolibrary.org/obo/MONDO_0010088 |
T158 | 148-151 | Disease | denotes | MSD | http://purl.obolibrary.org/obo/MONDO_0010088 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T105 | 0-2 | http://purl.obolibrary.org/obo/CLO_0001869 | denotes | BB |
T106 | 6-7 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T128 | 0-2 | Chemical | denotes | BB | http://purl.obolibrary.org/obo/CHEBI_53109 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T178 | 0-178 | Sentence | denotes | BB is a consultant to Baxalta, Celgene, MSD, Mundipharma and received Honoraria and Research funding from Astellas, Celgene, J&J, Maquet, Miltenyi, MSD, Takeda, Roche and Sanofi. |